# A Study to Examine the Effect of Omeprazole, Famotidine, and an Acidic Beverage on the Pharmacokinetics of Entinostat in Healthy Adult Subjects

> **NCT02922933** · PHASE1 · COMPLETED · sponsor: **Syndax Pharmaceuticals** · enrollment: 66 (actual)

## Conditions studied

- Volunteers
- Healthy Volunteers
- Human Volunteers
- Normal Volunteers

## Interventions

- **DRUG:** entinostat
- **DIETARY_SUPPLEMENT:** Omeprazole
- **DIETARY_SUPPLEMENT:** Famotidine

## Key facts

- **NCT ID:** NCT02922933
- **Lead sponsor:** Syndax Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-25
- **Primary completion:** 2017-04-19
- **Final completion:** 2017-05-08
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2018-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02922933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02922933, "A Study to Examine the Effect of Omeprazole, Famotidine, and an Acidic Beverage on the Pharmacokinetics of Entinostat in Healthy Adult Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02922933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*